ArticleScientific reports2020

Targeting interleukin-17 receptor B enhances gemcitabine sensitivity through downregulation of mucins in pancreatic cancer.

Lung-Hung Tsai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.